esrp know that the real estate needs of the Life Sciences/Biotech industry during COVID-19 has stretched an already thin real estate inventory in most markets. Biotech/pharma firms have tended to cluster when choosing sites and creating jobs in Boston, San Francisco, Raleigh-Durham, and San Diego. These markets have well-established research universities, a large talent pool, lab space, and available venture capital/NIH funding. However, other markets are emerging such as Dallas-Fort Worth, Houston, Austin, and Denver that may allow greater savings in labor and real estate. This is good news for Life Sciences/Biotech tenants who are more concerned than ever about preserving capital, building flexible spaces, and creating innovation clusters to appeal to a wider customer base.
Let our Life Sciences team share our powerful insights into these emerging markets.
Technology Based – Data Driven
Book a session with our team to help plan and execute your 2021-2022 strategies. We deliver answers in days, not weeks.
These powerful insights are included in our real estate services…not an expensive study you pay for additionally or have to decipher for yourself.